Ondansetron and Common peroneal nerve dysfunction - a phase IV clinical study of FDA data
Summary:
Common peroneal nerve dysfunction is reported as a side effect among people who take Ondansetron (ondansetron), especially for people who are female, 60+ old, have been taking the drug for < 1 month also take Dexamethasone, and have Multiple myeloma.
The phase IV clinical study analyzes which people have Common peroneal nerve dysfunction when taking Ondansetron. It is created by eHealthMe based on reports of 122,217 people who have side effects when taking Ondansetron from the FDA, and is updated regularly.
What is Ondansetron?
Ondansetron has active ingredients of ondansetron. It is often used in nausea. eHealthMe is studying from 122,739 Ondansetron users. Check the latest studies of Ondansetron.
What is Common peroneal nerve dysfunction?
Common peroneal nerve dysfunction (dysfunction of nerve controlling movement and sensation to the lower leg, foot and toes) is found to be associated with 651 drugs and 1,131 conditions by eHealthMe. Check the latest studies of Common peroneal nerve dysfunction.
eHealthMe: drug outcomes in the real world
eHealthMe runs one of the largest post-marketing drug safety studies in the world. We study millions of patients and 5,000 more each day. Our data-driven phase IV clinical trials have been referenced on 800+ peer-reviewed medical publications including The Lancet, Mayo Clinic Proceedings, and Nature. Tools to study our phase IV findings are available to the public, anonymous and free >>>.
122,217 people reported to have side effects when taking Ondansetron.
Among them, 54 people (0.04%) have Common peroneal nerve dysfunction.

Among these 54 people:
How long have people been on Ondansetron when they have Common peroneal nerve dysfunction? *
- < 1 month: 100 %
- 1 - 6 months: 0.0 %
- 6 - 12 months: 0.0 %
- 1 - 2 years: 0.0 %
- 2 - 5 years: 0.0 %
- 5 - 10 years: 0.0 %
- 10+ years: 0.0 %
What is the gender of people who have Common peroneal nerve dysfunction when taking Ondansetron? *
- female: 69.81 %
- male: 30.19 %
What is the age of people who have Common peroneal nerve dysfunction when taking Ondansetron? *
- 0-1: 0.0 %
- 2-9: 4.35 %
- 10-19: 4.35 %
- 20-29: 0.0 %
- 30-39: 10.87 %
- 40-49: 21.74 %
- 50-59: 26.09 %
- 60+: 32.61 %
What are other drugs people take besides Ondansetron? *
- Dexamethasone: 20 people, 37.04%
- Omeprazole: 19 people, 35.19%
- Furosemide: 15 people, 27.78%
- Azithromycin: 14 people, 25.93%
- Metronidazole: 14 people, 25.93%
- Morphine: 14 people, 25.93%
- Mobic: 13 people, 24.07%
- Aspirin: 12 people, 22.22%
- Ranitidine: 11 people, 20.37%
- Prilosec: 10 people, 18.52%
What are other side effects people have besides Common peroneal nerve dysfunction? *
- Weakness: 26 people, 48.15%
- Fatigue (feeling of tiredness): 21 people, 38.89%
- Neuropathy Peripheral (surface nerve damage): 20 people, 37.04%
- Pain In Extremity: 19 people, 35.19%
- Pain: 19 people, 35.19%
- Fall: 17 people, 31.48%
- Emotional Distress: 15 people, 27.78%
- Stress And Anxiety: 14 people, 25.93%
- Eating Disorder: 14 people, 25.93%
- Pain In Jaw: 14 people, 25.93%
What are the existing conditions these people have? *
- Multiple Myeloma (cancer of the plasma cells): 13 people, 24.07%
- Multiple Sclerosis (a nervous system disease that affects your brain and spinal cord. it damages the myelin sheath): 9 people, 16.67%
- Gait Disturbance: 7 people, 12.96%
- Pain: 7 people, 12.96%
- Breast Cancer: 5 people, 9.26%
- Hypercalcaemia (elevated calcium (ca+) level in the blood): 5 people, 9.26%
- Breast Cancer Metastatic: 4 people, 7.41%
- Infection: 4 people, 7.41%
- Muscle Spasms (muscle contraction): 4 people, 7.41%
- Acute Myeloid Leukaemia (acute cancer in which the bone marrow makes abnormal myeloblasts): 3 people, 5.56%
* Approximation only. Some reports may have incomplete information.
Do you take Ondansetron and have Common peroneal nerve dysfunction?
- Check whether Common peroneal nerve dysfunction is associated with a drug or a condition
- Predict drug outcomes for up to one year with AI
- Get an AI agent to monitor your drugs continuously
Related studies:
Effectiveness of, long term effects of, and alternative drugs to Ondansetron:
- Ondansetron (122,739 reports)
Common peroneal nerve dysfunction treatments and more:
- Common peroneal nerve dysfunction (7,841 reports)
How severe was Common peroneal nerve dysfunction and when was it recovered:
Expand to all the drugs that have ingredients of ondansetron:
Sub-studies by gender and age:
Female: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Male: 0-1 2-9 10-19 20-29 30-39 40-49 50-59 60+
Browse all side effects of Ondansetron:
a b c d e f g h i j k l m n o p q r s t u v w x y zBrowse all the drugs that are associated with Common peroneal nerve dysfunction:
- Common peroneal nerve dysfunction (651 drugs)
Browse all the conditions that are associated with Common peroneal nerve dysfunction:
- Common peroneal nerve dysfunction (1,131 conditions)
How the study uses the data?
The study uses data from the FDA. It is based on ondansetron (the active ingredients of Ondansetron) and Ondansetron (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.
How to use the study?
DO NOT STOP MEDICATIONS without first consulting your doctor. If there are any serious or long term adverse effects discovered in the study, discuss the study with your doctor to ensure that proper medication management will be in place if applicable.
Who is eHealthMe?
With medical big data and proven AI/ML algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 800+ peer-reviewed medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).
WARNING, DISCLAIMER, USE FOR PUBLICATION
WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.
DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.
If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.
Recent studies on eHealthMe:
- Could Skyrizi cause Stools - Watery? - a second ago
- Could Abilify cause Oesophageal Disorder? - a second ago
- Could Skyrizi cause Diarrhea? - 2 seconds ago
- Could Diphenhydramine Hydrochloride cause Raynaud'S Phenomenon? - 8 seconds ago
- Could Chlorthalidone cause Anaemia? - 19 seconds ago
- Could Chlorzoxazone cause Dyspnea Exacerbated? - 20 seconds ago
- Drug interactions of Sudafed and Wellbutrin - 23 seconds ago
- Could Meloxicam cause Oesophageal Mucosal Hyperplasia? - 23 seconds ago
- Drug interactions of Verapamil Hydrochloride and Veltassa - 24 seconds ago
- Could Lamisil cause Ulcerative Colitis? - 31 seconds ago